Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Implementation of infliximab standardized doses after pharmacokinetic modelization in a cohort of patients with Crohn's disease.

Poullenot F, Ollivier J, Rivière P, Sauvaget L, Berroneau A, Djabarouti S, Xuereb F, Zerbib F, Breilh D, Laharie D.

Dig Liver Dis. 2019 Dec 21. pii: S1590-8658(19)30927-2. doi: 10.1016/j.dld.2019.11.018. [Epub ahead of print]

PMID:
31874834
2.

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

Ollivier J, Carrié C, d'Houdain N, Djabarouti S, Petit L, Xuereb F, Legeron R, Biais M, Breilh D.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02134-18. doi: 10.1128/AAC.02134-18. Print 2019 Mar.

3.

Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion.

Carrié C, Legeron R, Petit L, Ollivier J, Cottenceau V, d'Houdain N, Boyer P, Lafitte M, Xuereb F, Sztark F, Breilh D, Biais M.

J Crit Care. 2018 Dec;48:66-71. doi: 10.1016/j.jcrc.2018.08.026. Epub 2018 Aug 23.

PMID:
30172963
4.

A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.

Legeron R, Xuereb F, Chaignepain S, Gadeau AP, Claverol S, Dupuy JW, Djabarouti S, Couffinhal T, Schmitter JM, Breilh D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Dec 1;1070:43-53. doi: 10.1016/j.jchromb.2017.10.042. Epub 2017 Oct 23.

PMID:
29111437
5.

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.

Streicher C, Djabarouti S, Xuereb F, Lazaro E, Legeron R, Bouchet S, Greib C, Breilh D, Pellegrin JL, Viallard JF.

Br J Clin Pharmacol. 2014 Dec;78(6):1419-25. doi: 10.1111/bcp.12462.

6.

Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage.

Legeron R, Xuereb F, Djabarouti S, Saux MC, Breilh D.

Am J Health Syst Pharm. 2013 Dec 1;70(23):2137-42. doi: 10.2146/ajhp120372.

PMID:
24249764
7.

Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.

Boselli E, Breilh D, Caillault-Sergent A, Djabarouti S, Guillaume C, Xuereb F, Bouvet L, Rimmelé T, Saux MC, Allaouchiche B.

J Antimicrob Chemother. 2012 May;67(5):1207-10. doi: 10.1093/jac/dks022. Epub 2012 Feb 20.

PMID:
22351682
8.

A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid-phase extraction.

Mosnier-Thoumas S, Djabarouti S, Xuereb F, Lazaro E, Pellegrin JL, Saux MC, Breilh D.

J Pharm Pharmacol. 2011 Dec;63(12):1559-65. doi: 10.1111/j.2042-7158.2011.01368.x.

PMID:
22060286
9.

Quantitative analysis of erythropoietin in human plasma by tandem mass spectrometry.

Xuereb F, Chaignepain S, Breilh D, Godde F, Saux MC, Lenz C, Glueckmann M, Schmitter JM.

Anal Bioanal Chem. 2011 Jun;400(7):2073-84. doi: 10.1007/s00216-011-4897-3. Epub 2011 Mar 29.

PMID:
21445661
10.

An in vitro study of epoetin beta intravenous injection site at the end of hemodialysis.

Xuereb F, de Précigout V, Combe C, Sinnasse-Raymond G, Saux MC, Breilh D.

Int J Pharm. 2010 Aug 30;396(1-2):140-2. doi: 10.1016/j.ijpharm.2010.06.010. Epub 2010 Jun 11.

PMID:
20542102
11.

Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia.

Boselli E, Breilh D, Rimmelé T, Guillaume C, Xuereb F, Saux MC, Bouvet L, Chassard D, Allaouchiche B.

Crit Care Med. 2008 May;36(5):1500-6. doi: 10.1097/CCM.0b013e318170ba21.

PMID:
18434883
12.

Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients.

Boselli E, Breilh D, Djabarouti S, Guillaume C, Rimmelé T, Gordien JB, Xuereb F, Saux MC, Allaouchiche B.

Intensive Care Med. 2007 Sep;33(9):1519-23. Epub 2007 May 25.

PMID:
17530217
13.

Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry.

Rouzes A, Berthoin K, Xuereb F, Djabarouti S, Pellegrin I, Pellegrin JL, Coupet AC, Augagneur S, Budzinski H, Saux MC, Breilh D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):209-16.

PMID:
15556535
14.

Determination of linezolid in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.

Toutain J, Boselli E, Djabarouti S, Allaouchiche B, Xuereb F, Bernadou JM, Ba B, Saux MC, Breilh D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):145-50.

PMID:
15556527
15.

Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study).

Breilh D, Pellegrin I, Rouzés A, Berthoin K, Xuereb F, Budzinski H, Munck M, Fleury HJ, Saux MC, Pellegrin JL.

AIDS. 2004 Jun 18;18(9):1305-10.

PMID:
15362663
16.

Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia.

Boselli E, Breilh D, Cannesson M, Xuereb F, Rimmelé T, Chassard D, Saux MC, Allaouchiche B.

Intensive Care Med. 2004 May;30(5):976-9. Epub 2004 Apr 1.

PMID:
15057512
17.

Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.

Breilh D, Jougon J, Djabarouti S, Gordien JB, Xuereb F, Velly JF, Arvis P, Landreau V, Saux MC.

J Chemother. 2003 Dec;15(6):558-62.

PMID:
14998080

Supplemental Content

Loading ...
Support Center